Dr. Peter Gregory Gordon, MD

Dr. Gordon practices at Columbia University Irving Medical Center in New York, New York.

Dr. Gordon's NPI, 1093838856, was assigned on April 9, 2007. Dr. Gordon graduated from Renaissance School of Medicine at Stony Brook University in 1990. Dr. Gordon holds New York license 188525.

Dr. Gordon's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.

Dr. Gordon's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Gordon is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Gordon to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gordon practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Gordon's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Gordon is board certified in internal medicine by the American Board of Internal Medicine. Dr. Gordon is licensed in New York.

Dmand AI lists asthma, chronic diabetes, chronic hypertension, chronic obstructive pulmonary disease (COPD), circulatory problems in extremities, depression, diabetic emergency and drug use disorders among the conditions Dr. Gordon treats.

CMS data shows 131 Medicare services from Dr. Gordon across 3 procedure codes in 2024, for 56 Medicare patients. Medicare paid $7,161 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 56 Medicare patients who saw Dr. Gordon in 2024. The largest group is 65 to 74, with 24 patients. 73% of them have high blood pressure, and 63% have high cholesterol. 75% are also on Medicaid. Their average risk score is 3.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gordon's median patient age at 69, with 30% women.

In 2024, Dr. Gordon wrote 2,318 Medicare Part D claims for 67 patients. 64% of them were for generic drugs. CMS names the drug for 2,037 of them, across 62 drugs with 11 or more claims each, at $1,765,243 in total drug cost. In 2023, CMS named 1,735 claims across 50 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Gordon for performance year 2024, reported through an alternative payment model (APM). Dr. Gordon accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 30 papers to Dr. Gordon, published from 2007 to 2024. 2016 was the busiest year, with 3. The most frequent topics are HIV Infections, New York City and Electronic Health Records. Dr. Gordon has published most often in Open Forum Infect Dis. Dr. Gordon's most frequent co-authors are Jason E. Zucker, MD, Bruce Agins, MD and Alwyn Cohall, MD.

CMS Open Payments shows 7 general payments to Dr. Gordon from 2 drug and device companies from 2017 to 2022. Travel and lodging make up the largest share, 83% of the total. Gilead Sciences, Inc. paid the most, $2,286.

Dr. Gordon graduated from Renaissance School of Medicine at Stony Brook University in 1990.

Dr. Gordon is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.